> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Extends PMA Review for Nuvectra’s Urological Device
- URL: https://www.fdaweb.com/fda-extends-pma-review-for-nuvectras-urological-device/
- Published: 2019-01-30T12:00:00.000Z
- Updated: 2026-09-15T00:59:06.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5143253

FDA has extended its review of a Nuvectra PMA for its Virtis Sacral Neuromodulation system. “FDA has informed us that they have not yet concluded their review and as such will require an extension of our 180-day review period,” the company says. “To date, FDA has not identified any additional deficiencies or requested any additional information.” The device is being reviewed by the agency for use in treating chronic urinary retention and symptoms of overactive bladder.